Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 5, 2025
Inhibition of NEDDylation enhances the cytostatic effect of Rohinitib on chronic lymphocytic leukemia cellsJose Luis Castaño, Víctor Arenas, Juan José Domínguez, et al.
European Journal of Internal Medicine|December 3, 2023
Features of immune mediated diseases in JAK2 (V617F)-positive myeloproliferative neoplasms and the potential therapeutic role of JAK inhibitorsCarmen Álvarez-Reguera, Diana Prieto-Peña, Alba Herrero-Morant, et al.
Clinical Chemistry and Laboratory Medicine|November 15, 2024
Allowable total error in CD34 cell analysis by flow cytometry based on state of the art using Spanish EQAS dataSara Fernández-Luis, Alejandra Comins-Boo, Fernando Pérez-Pla, et al.
American Journal of Physiology. Endocrinology and Metabolism|January 8, 2015
Cyclin C stimulates β-cell proliferation in rat and human pancreatic β-cellsMargarita Jiménez-Palomares, José Francisco López-Acosta, Pablo Villa-Pérez, et al.
Transplantation and Cellular Therapy|November 27, 2022
Feasibility of a Hospital-at-Home Program for Autologous Hematopoietic Stem Cell TransplantationSoledad González-Barrera, Guillermo Martín-Sánchez, Juan José Parra-Jordán, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 31, 2024
Is Bone Marrow Trephine Biopsy Necessary in Multiple Myeloma Patients at Diagnosis?Ana Gea, Tatiana Fernández, Sara Fernández-Luis, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 12, 2025
Changes in the bacterial profile and diversity of the gut microbiota in allogeneic hematopoietic stem cell transplant recipientsClaudia González-Rico, Marta Hernández, Jorge Rodríguez-Grande, et al.
Transplantation and Cellular Therapy|July 9, 2026
FEASIBILITY AND INTERIM SAFETY AND EFFICACY ANALYSIS OF A FAST AUTOMATED PRODUCTION OF PROPHYLACTIC CMV-SPECIFIC CTLs AFTER ALLOGENEIC HSCTMa Aránzazu Bermúdez, Oscar M Pello, Miriam Sánchez-Escamilla, et al.
Annals of Hematology|June 24, 2025
Prognostic factors of survival in second allogeneic hematopoietic transplantationRodrigo Cantera Estefanía, Raquel García Ruiz, Sara Fernández-Luis, et al.
Blood Cancer Journal|March 22, 2025
Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC)Carlos Jiménez-Vicente, Jordi Esteve, Mónica Baile-González, et al.
Pageof 2